Advertisement
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
AJMC INTERVIEWS
Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.
AJMC INTERVIEWS
Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at “Patient-Centered Diabetes Care: Putting Theory into Practice,” sponsored by The American Journal of Managed Care.
Dr Dunn introduces the discussion of benefit design, suggesting that managed care providers may be unprepared to administer specialty drugs.
Susannah Higgins, MS; Ravi Chawla, MBA; Christine Colombo, MBA; Richard Snyder, MD; and Somesh Nigam, PhD
Christopher S. Hollenbeak, PhD; Mark G. Weiner, MD; and Barbara J. Turner, MD, MSED
Caterina F. Hill, MSc, MA (Cantab); Brian W. Powers, AB; Sachin H. Jain, MD, MBA; Jennifer Bennet, BS; Anthony Vavasis, MD; and Nancy E. Oriol, MD
Current Issue | Archives
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscan™)
Effective and Efficient Diagnosis of Parkinsonism: The Role of Dopamine Transporter SPECT Imaging With Ioflupane I-123 Injection (DaTscan™)
Volume: 20
Number: 5 Suppl
Number: 5 Suppl
Sara C. Erickson, PharmD; Wenyi Qiu, MS; Crystal R. Maas-Patel, PharmD; Sharon M. Wang, PharmD, MS; and Bimal V. Patel, PharmD, MS
Myrl Weinberg, FASAE, CAE
Catherine I. Starner, PharmD, BCPS; R. Scott McClelland, PharmD; Yang Qiu, MS; Richard A. Zabinski, PharmD; Nancy Cotter, PharmD; and Patrick P. Gleason, PharmD, BCPS, FCCP
Mary K. Caffrey
Andrew D. Smith
Jennifer L. Redmond, DrPH
Mary K. Caffrey
Stanton R. Mehr
Leah Schmidt, SNS
Advertisement
Thursday, April 17th, 2014
New Medicaid Generic Reimbursement Rates Receive Push BackKatie Sullivan, MA
A US Department of Health and Human Services (HHS) analysis determined that a new payment formula, which would reduce Medicaid reimbursement rates for generic prescription drugs, could save Medicaid up to $1.2 billion per year. So why are pharmacists and drug manufacturers pushing back?
Groundbreaking hepatitis C therapies represent a new era in treatment. But their cost is unprecedented, meaning health plans and PBMs are facing difficult formulary decisions.
Advertisement
Advertisement
About Us | Contact Us | Terms & Conditions | Privacy Policy | Press Room | Copyright HCPLive 2006-2014 | Intellisphere, LLC. All Rights Reserved.
Partner Websites: Pharmacy Times | Targeted Therapies | PainLive | HCPLive | ONCLive | Specialty Pharmacy Times